A conformationally sensitive residue on the cytoplasmic surface of serotonin transporter

被引:42
作者
Androutsellis-Theotokis, A [1 ]
Ghassemi, F [1 ]
Rudnick, G [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA
关键词
D O I
10.1074/jbc.M107462200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serotonin transporter (SERT) contains a single reactive external cysteine residue at position 109 (Chen, J. G., Liu-Chen, S., and Rudnick, G. (1997) Biochemistry 36, 1479-1486) and seven predicted cytoplasmic cysteines. A mutant of rat SERT (X8C) in which those eight cysteine residues were replaced by other amino acids retained similar to 32% of wild type transport activity and similar to 56% of wild type binding activity. In contrast to wild-type SERT or the C109A mutant, X8C was resistant to inhibition of high affinity cocaine analog binding by the cysteine reagent 2-(aminoethyl)methanethiosulfonate hydrobromide (MTSEA) in membrane preparations from transfected cells. Each predicted cytoplasmic cysteine residue was reintroduced, one at a time, into the X8C template. Reintroduction of Cys-357, located in the third intracellular loop, restored MTSEA sensitivity similar to that of C109A. Replacement of only Cys-109 and Cys-357 was sufficient to prevent MTSEA sensitivity. Thus, Cys-357 was the sole cytoplasmic determinant of MTSEA sensitivity in SERT. Both serotonin and cocaine protected SERT from inactivation by MTSEA at Cys-357. This protection was apparently mediated through a conformational change following ligand binding. Although both ligands bind in the absence of Na+ and at 4 degreesC, their ability to protect Cys-357 required Na+ and was prevented at 4 degreesC. The accessibility of Cys-357 to MTSEA inactivation was increased by monovalent cations. The K+ ion, which is believed to serve as a countertransport substrate for SERT, was the most effective ion for increasing Cys-357 reactivity.
引用
收藏
页码:45933 / 45938
页数:6
相关论文
共 41 条
[1]   NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS [J].
AMARA, SG ;
KUHAR, MJ .
ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 :73-93
[2]  
Barker EL, 1999, J NEUROSCI, V19, P4705
[3]   High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis - An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol [J].
Barker, EL ;
Perlman, MA ;
Adkins, EM ;
Houlihan, WJ ;
Pristupa, ZB ;
Niznik, HB ;
Blakely, RD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) :19459-19468
[4]   VACCINIA-T7 RNA-POLYMERASE EXPRESSION SYSTEM - EVALUATION FOR THE EXPRESSION CLONING OF PLASMA-MEMBRANE TRANSPORTERS [J].
BLAKELY, RD ;
CLARK, JA ;
RUDNICK, G ;
AMARA, SG .
ANALYTICAL BIOCHEMISTRY, 1991, 194 (02) :302-308
[5]   CLONING AND EXPRESSION OF A FUNCTIONAL SEROTONIN TRANSPORTER FROM RAT-BRAIN [J].
BLAKELY, RD ;
BERSON, HE ;
FREMEAU, RT ;
CARON, MG ;
PEEK, MM ;
PRINCE, HK ;
BRADLEY, CC .
NATURE, 1991, 354 (6348) :66-70
[6]  
BORDEN LA, 1992, J BIOL CHEM, V267, P21098
[7]   POTENTIAL INDICATIONS FOR THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS [J].
BOYER, WF .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1992, 6 :5-12
[8]   Permeation and gating residues in serotonin transporter [J].
Chen, JG ;
Rudnick, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1044-1049
[9]   External cysteine residues in the serotonin transporter [J].
Chen, JG ;
LiuChen, S ;
Rudnick, G .
BIOCHEMISTRY, 1997, 36 (06) :1479-1486
[10]   The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding [J].
Chen, JG ;
Sachpatzidis, A ;
Rudnick, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28321-28327